Albumin ISH performed exceptionally well in poorly differentiated HCC, where traditional markers often underperform: Albumin ISH maintained a sensitivity of 99% in poorly differentiated HCCs, significantly surmounted both Arg-1 (71%) and HepPar1 (64%) [22]. The gene discussed is ALB; the disease is hepatocellular carcinoma.